Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, shared on LinkedIn:
“I’m happy to share that I’m starting a new position as Track Co-Chair: WCLC 2027: Metastatic NSCLC – ADCs and Cytotoxic Therapy at International Association for the Study of Lung Cancer!”
This also can be interesting:
